A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Older Adults in Korea
A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Older Adults in Korea
Category & Conditions: Vaccine-related Conditions
Medicine: PF-06928316
ClinicalTrials.gov Identifier (NCT): NCT06593587
Protocol ID: C3671053
Open Plain Language Summary Result:
Click here